Moving forward in smoking cessation: Issues for psychiatric nurses

Journal of the American Psychiatric Nurses Association

Volumn 15, Issue 1, 2009, Pages 68-72

  Schroeder, Steven A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62749144478     PISSN: 10783903     EISSN: 15325725     Source Type: Journal    
DOI: 10.1177/1078390308330843     Document Type: Editorial

References (42)

1. American Association of Medical Colleges. (2007). Physician behavior and practice patterns related to smoking cessation. Retrieved November 2, 2008, from http://www.aamc.org/workforce/smoking-cessation-full.pdf
2. American Psychiatric Nurses Association. (2008). Smoking cessation position statement: Psychiatric nurses as champions for smoking cessation. Retrieved November 12, 2008, from http://www.apna.org/i4a/ pages/index.cfm?pageid=3751
3. Benowitz, N.L. (2008). Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics, 83, 531-541.
4. Bjornson, W. (2008, January). Bringing everyone along resource guide: For health professional providing tobacco cessation services for people with mental illness and substance use disorder. Portland, OR: Tobacco Cessation Leadership Network.
5. Brown, R.A., Kahler, C.W., Niaura, R., Abrams, D.B., Sales, S.D., Ramsey, S.E., et al. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480.
6. Brown, R.A., Niaura, R., Lloyd-Richardson, E.E., Strong, D.R., Kahler, C.W., Abrantes, A.M., et al. (2007). Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-730.
7. Burke, M. (2006). Technical report on smoking policy and treatment in state operated psychiatric facilities. In J. Parks & P. Jewell (Eds.), Technical report 12. Alexandria, VA: National Association of State Mental Health Program Directors Medical Directors Council.
8. Centers for Disease Control and Prevention. (2002). Cigarette smoking among adults-United States, 2000. Morbidity and Mortality Weekly Report, 51, 642-645.
9. Centers for Disease Control and Prevention. (2008, November 14). Cigarette smoking among adults-United States, 2007. Morbidity and Mortality Weekly Report, 57, 1221-1226.
10. Christakis, N.A., & Fowler, J.H. (2008). The collective dynamics of smoking in a large social network. New England Journal of Medicine, 358, 2249-2258.
11. Colton, C.W., & Manderscheid, R.W. (2006, April). Congruencies in increased mortality rates, years of potential lives lost, and causes of death among public health mental clients in eight states [Electronic version]. Preventing Chronic Disease, 3 (2). Retrieved November 1, 2008, from http://cdc.gov/pcd/issues/2006/Apr/05_0180.htm
12. Dierker, L.C., Avenevoli, S., Merikangas, K.R., Flaherty, B.P., & Stolar, M. (2001). Association between psychiatric disorders and the progression of tobacco use behaviors. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1159-1167.
13. Fiore, M.C., Jaen, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., et al. (2008). Treating tobacco use and dependence: 2008 Update. Practice guideline. Rockville, MD: Public Health Service.
14. Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., MacGregor, R., et al. (1996). Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379, 733-736.
15. Gonzales, D., Rennard, S.I., Nides, M., Oncken, C., Azoulay, S., Billing, C.B., et al. (2006). Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55.
16. Grant, B.F., Hasin, D.S., Chou, P., Stinson, F.S., & Dawson, D.A. (2004). Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 1107-1115.
17. Hays, J.T., & Ebbert, J.O. (2008). Varenicline for tobacco dependence. New England Journal of Medicine, 359, 2018-2024.
18. Jorenby, D.E., Hays, J.T., Rigotti, N.A., Azoulay, S., Watsky, E.J., Williams, K.E., et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetaldehyde receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 56-63.
19. Kalman, D., Morissette, S.B., & George, T.P. (2005). Co-morbidity of smoking in patients with psychiatric and substance abuse disorders. American Journal on Addictions, 14, 106-123.
20. Lasser, K., Boyd, J.W., Woolhandler, S., Himmelstein, D.U., McCormick, D., & Bor, D.H. (2000). Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association, 284, 2606-2610.
21. Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N.R., Bowman, E.D., et al. (1998). Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychology, 17, 56-62.
22. Levin, A. (2007). State hospitals struggle to give up smoking. Psychiatric News, 42(22), 4.
23. Lucksted, A., McGuire, C., Postrado, L., Kreyenbuhl, J., & Dixon, L.B. (2004). Specifying cigarette smoking and quitting among people with serious mental illness. American Journal on Addictions, 13, 128-138.
24. Mauer, B. (2006). Morbidity and mortality in people with serious mental illness. In J. Parks, D. Svendsen, P. Singer, & M. E. Foti (Eds.), Technical report 13. Alexandria, VA: National Association of State Mental Health Program Directors Council.
25. McCaffery, J.M., Niaura, R., Swan, G.E., & Carmelli, D. (2003). A study of depressive symptoms and smoking behavior in adult male white twins from the NHLBI twin study. Nicotine & Tobacco Research, 5, 77-83.
26. Mechanic, D., Blider, S., & McAlpine, D.D. (2002). Employing persons with serious mental illness. Health Affairs (Project Hope), 21, 242-253.
27. Paperwalla, K.N., Levin, T.T., Weiner, J., & Saravay, S.M. (2004). Smoking and depression. Medical Clinics of North America, 88, 1483-1494.
28. Prochaska, J.J., Rossi, J.S., Redding, C.A., Rosen, A.B., Tsoh, J.Y., Humfleet, G.L., et al. (2004). Depressed smokers and stage of change: Implications for treatment interventions. Drug and Alcohol Dependence, 76, 143-151.
29. Prochaska, J.O., DiClemente, C.C., & Norcross, J.C. (1992). In search of how people change. Applications to addictive behaviors. American Psychologist, 47, 1102-1114.
30. The Regents of the University of California, University of Southern California, and Western University of Health Sciences. (2007). Rx for change: Clinician-assisted tobacco cessation. San Francisco: Author. Retrieved November 2, 2008, from http://rxforchange.ucsf.edu
31. Reilly, P., Murphy, L., & Alderton, D. (2006). Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health Nursing, 15, 272-278.
32. Sánchez-Villegas, A., Serrano-Martínez, M., Alonso, A., de Irala, J., Tortosa, A., & Martínez-González, M.A. (2008). Role of tobacco use on the incidence of depression in the SUN cohort study. Medicina Clínica, 130, 405-409.
33. Schroeder, S.A. (2007 a). Shattuck Lecture. We can do better - Improving the health of the American people. New England Journal of Medicine, 357, 1221-1228.
34. Schroeder, S.A. (2007b, November 18). A hidden epidemic. Washington Post, p. B07.
35. Schroeder, S.A. (2008). Stranded in the periphery - The increasing marginalization of smokers. New England Journal of Medicine, 358, 2284-2296.
36. Schroeder, S.A. (in press). Clinical crossroads: A 51-year-old woman with bipolar disorder who wants to quit smoking. Journal of the American Medical Association.
37. Schroeder, S.A., & Sox, H.C. (2006). Trials that matter: Varenicline: A designer drug to help smokers quit. Annals of Internal Medicine, 145, 784-785.
38. Steinberg, M.L., Williams, J.M., & Ziedonis, D.M. (2004). Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control, 13, 206.
39. Tsoh, J.Y., & Hall, S.M. (2004). Depression and smoking: From the transtheoretical model of change perspective. Addictive Behaviors, 29, 801-805.
40. Williams, J.M. (2008). Eliminating tobacco use in mental health facilities: Patients' rights, public health, and policy issues. Journal of the American Medical Association, 299, 571-573.
41. Williams, J.M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067-1083.
42. Ziedonis, D.M., Kosten, T.R., Glazer, W.M., & Frances, R.J. (1994). Nicotine dependence and schizophrenia. Hospital & Community Psychiatry, 45, 204-206.